SEC Form 4 · accession 0001053369-15-000009
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
EPIC PHARMA LLC
10% Owner
Period of report
Apr 3, 2015
Accepted (ET)
Apr 7, 2015 · 8:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantsF2 | $0.0625 | Apr 3, 2015 | J | 2,454,665 | D | Jun 3, 2009 | Jun 3, 2016 | Common Stock | 2,454,665 | 0 | I |
| WarrantsF2 | $0.0625 | Apr 3, 2015 | J | 6,726,999 | D | Oct 30, 2009 | Oct 30, 2016 | Common Stock | 6,726,999 | 0 | I |
| WarrantsF2 | $0.0625 | Apr 3, 2015 | J | 40,000,000 | D | Mar 31, 2011 | Mar 31, 2018 | Common Stock | 40,000,000 | 0 | I |
| WarrantsF2 | $0.0625 | Apr 3, 2015 | J | 4,000,000 | D | Apr 25, 2011 | Apr 25, 2018 | Common Stock | 4,000,000 | 0 | I |
Explanation of responses
- F1Disposition of warrants to its members
- F2The reporting person, Epic Pharma, LLC ("EP") owns 100% of the outstanding equity interests, is an equity owner of Epic Investments, LLC ("EI"). The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.